Skip to main content
Top
Published in: Italian Journal of Pediatrics 2/2018

Open Access 01-11-2018 | Review

Mucopolysaccharidoses: early diagnostic signs in infants and children

Authors: Cinzia Galimberti, Annalisa Madeo, Maja Di Rocco, Agata Fiumara

Published in: Italian Journal of Pediatrics | Special Issue 2/2018

Login to get access

Abstract

Mucopolysaccharidoses (MPS) comprise a group of lysosomal disorders that are characterized by progressive, systemic clinical manifestations and a coarse phenotype. The different types, having clinical, biochemical, and genetic heterogeneity, share key clinical features in varying combinations, including joint and skeletal dysplasia, coarse facial features, corneal clouding, inguinal or abdominal hernias, recurrent upper respiratory tract infections, heart valve disease, carpal tunnel syndrome, and variable neurological involvement. In the severe forms, these features usually appear in the first months of life, but a correct diagnosis is often reached later when suggestive signs are manifest. All MPS types may have severe or attenuated presentations depending on the residual enzymatic activity of the patient. Based on data from the literature and from personal experience, here we underline the very early signs of the severe forms which should alert the paediatrician on their first appearance. A few early signs are typical of MPS (i.e. gibbus) while many are unspecific (hernias, upper airway infections, organomegaly, etc.), and finding the association of many unspecific signs might prompt the paediatrician to search for a common cause and to carefully look for other more specific signs (gibbus and other skeletal deformities, heart murmur). We stress the need to increase awareness of MPS among paediatricians and other specialists to shorten the still existing diagnostic delay. A timely diagnosis is mandatory for the commencement of treatment as soon as possible, when available, to possibly obtain better results.
Literature
2.
go back to reference Kiely BT, Kohler JL, Coletti HY, Poe MD, Escolar ML. Early disease progression of hurler syndrome. Orphanet J Rare Dis. 2017;2:32.CrossRef Kiely BT, Kohler JL, Coletti HY, Poe MD, Escolar ML. Early disease progression of hurler syndrome. Orphanet J Rare Dis. 2017;2:32.CrossRef
3.
go back to reference Wraith JE, Jones S. Mucopolysaccharidosis type I. Pediatr Endrocrinol Rev. 2014;12(Suppl 1):102–6. Wraith JE, Jones S. Mucopolysaccharidosis type I. Pediatr Endrocrinol Rev. 2014;12(Suppl 1):102–6.
4.
go back to reference Parini R, Jones SA, Harmatz PR, Giugliani R, Mendelsohn NJ. The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab. 2016;117(4):438–46.CrossRef Parini R, Jones SA, Harmatz PR, Giugliani R, Mendelsohn NJ. The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab. 2016;117(4):438–46.CrossRef
5.
go back to reference Bertola F, Filocamo M, Casati G, Mort M, Rosano C, Tylki-Szymanska A, et al. IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles. Hum Mutat. 2011;32(6):E2189–210.CrossRef Bertola F, Filocamo M, Casati G, Mort M, Rosano C, Tylki-Szymanska A, et al. IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles. Hum Mutat. 2011;32(6):E2189–210.CrossRef
6.
go back to reference Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121:227.CrossRef Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121:227.CrossRef
7.
go back to reference Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, et al., editors. The online metabolic and molecular bases of inherited disease (OMMBID). Chapter. New York, NY: McGraw-Hill; 2015. p. 136. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, et al., editors. The online metabolic and molecular bases of inherited disease (OMMBID). Chapter. New York, NY: McGraw-Hill; 2015. p. 136.
8.
go back to reference Scarpa M, Almassy Z, Beck M, Bodamer O, Bruce I, De Meirleir L, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;6:72.CrossRef Scarpa M, Almassy Z, Beck M, Bodamer O, Bruce I, De Meirleir L, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;6:72.CrossRef
9.
go back to reference Lonardo F, Di Natale P, Lualdi S, Acquaviva F, Cuoco C, Scarano F, et al. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation. Am J Med Genet A. 2627;164A:2014. Lonardo F, Di Natale P, Lualdi S, Acquaviva F, Cuoco C, Scarano F, et al. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation. Am J Med Genet A. 2627;164A:2014.
10.
go back to reference Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Muñoz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (hunter syndrome). Pediatrics. 2008;121:e377–86.CrossRef Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Muñoz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (hunter syndrome). Pediatrics. 2008;121:e377–86.CrossRef
11.
go back to reference Sheth J, Mistri M, Shah K, Chaudhary M, Godbole K, Sheth F. Lysosomal storage disorders in nonimmune hydrops fetalis (NIHF): an Indian experience. JIMD Rep. 2016; 35:47-52. Sheth J, Mistri M, Shah K, Chaudhary M, Godbole K, Sheth F. Lysosomal storage disorders in nonimmune hydrops fetalis (NIHF): an Indian experience. JIMD Rep. 2016; 35:47-52.
12.
go back to reference Beck M, Arn P, Giugliani R, Muenzer J, Okuyama T, Taylor J, et al. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759–65.CrossRef Beck M, Arn P, Giugliani R, Muenzer J, Okuyama T, Taylor J, et al. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759–65.CrossRef
13.
go back to reference Young ID, Harper PS. The natural history of the severe form of Hunter’s syndrome: a study based on 52 cases. Dev Med Child Neurol. 1983;25(4):481–9.CrossRef Young ID, Harper PS. The natural history of the severe form of Hunter’s syndrome: a study based on 52 cases. Dev Med Child Neurol. 1983;25(4):481–9.CrossRef
14.
go back to reference Clarke LA. Mucopolysaccharidosis type I. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., eds. GeneReviews [internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 31 Oct 2002 (updated 2016 11 Feb 2016). Clarke LA. Mucopolysaccharidosis type I. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., eds. GeneReviews [internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 31 Oct 2002 (updated 2016 11 Feb 2016).
15.
go back to reference Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, et al. Hunter outcome survey investigators. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med. 2010;12(12):816–22.CrossRef Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, et al. Hunter outcome survey investigators. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med. 2010;12(12):816–22.CrossRef
16.
go back to reference Scarpa M. Mucopolysaccharidosis type II. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., eds. GeneReviews [internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 6 Nov 2007 (updated 26 Mar 2015). Scarpa M. Mucopolysaccharidosis type II. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., eds. GeneReviews [internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 6 Nov 2007 (updated 26 Mar 2015).
17.
go back to reference Dam TA. Microcephaly in hurler syndrome. Clin Pediatr (Phila). 1997;36(1):51–2.CrossRef Dam TA. Microcephaly in hurler syndrome. Clin Pediatr (Phila). 1997;36(1):51–2.CrossRef
18.
go back to reference Tylki-Szymańska A. Mucopolysaccharidosis type II, Hunter's syndrome. Pediatr Endocrinol Rev. 2014;12(Suppl 1):107–13.PubMed Tylki-Szymańska A. Mucopolysaccharidosis type II, Hunter's syndrome. Pediatr Endocrinol Rev. 2014;12(Suppl 1):107–13.PubMed
19.
go back to reference Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr. 1973;82:249–57.CrossRef Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr. 1973;82:249–57.CrossRef
20.
go back to reference Pfeiffer RA, Kresse H, Bäumer N, Sattinger E. Beta-glucuronidase deficiency in a girl with unusual clinical features. Eur J Pediatr. 1977;126:155–61.CrossRef Pfeiffer RA, Kresse H, Bäumer N, Sattinger E. Beta-glucuronidase deficiency in a girl with unusual clinical features. Eur J Pediatr. 1977;126:155–61.CrossRef
21.
go back to reference Montaño AM, Lock-Hock N, Steiner RD, Graham BH, Szlago M, Greenstein R, et al. Clinical course of Sly syndrome (mucopolysaccharidosis type VII). J Med Genet. 2016;53(6):403–18.CrossRef Montaño AM, Lock-Hock N, Steiner RD, Graham BH, Szlago M, Greenstein R, et al. Clinical course of Sly syndrome (mucopolysaccharidosis type VII). J Med Genet. 2016;53(6):403–18.CrossRef
22.
go back to reference Nidiffer FD, Kelly TE. Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study. J Ment Defic Res. 1983;27:185–203.PubMed Nidiffer FD, Kelly TE. Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study. J Ment Defic Res. 1983;27:185–203.PubMed
23.
go back to reference Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit hyperactivity or autism spectrum disorder. Acta Paediatr. 2013;102:462–70.CrossRef Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit hyperactivity or autism spectrum disorder. Acta Paediatr. 2013;102:462–70.CrossRef
24.
go back to reference Bax MC, Colville GA. Behaviour in mucopolysaccharide disorders. Arch Dis Child. 1995;73(1):77–81.CrossRef Bax MC, Colville GA. Behaviour in mucopolysaccharide disorders. Arch Dis Child. 1995;73(1):77–81.CrossRef
25.
go back to reference Valstar MJ, Bruggenwirth HT, Olmer R, Wevers RA, Verheijen FW, Poorthuis BJ, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis. 2010;33:759.CrossRef Valstar MJ, Bruggenwirth HT, Olmer R, Wevers RA, Verheijen FW, Poorthuis BJ, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis. 2010;33:759.CrossRef
26.
go back to reference Heron B, Mikaeloff Y, Froissart R. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet 2010;research article:58–68.CrossRef Heron B, Mikaeloff Y, Froissart R. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet 2010;research article:58–68.CrossRef
27.
go back to reference Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, et al. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013;110:54–64.CrossRef Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, et al. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013;110:54–64.CrossRef
28.
go back to reference Caciotti A, Garman SC, Rivera-Colon Y, Procopio E, Catarzi S, et al. GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta. 2011;1812:782.CrossRef Caciotti A, Garman SC, Rivera-Colon Y, Procopio E, Catarzi S, et al. GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta. 2011;1812:782.CrossRef
29.
go back to reference Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio a registry: clinical manifestation and natural course of Morquio a disease. J Inherit Metab Dis. 2007;30:165–74.CrossRef Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio a registry: clinical manifestation and natural course of Morquio a disease. J Inherit Metab Dis. 2007;30:165–74.CrossRef
30.
go back to reference Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, et al. International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A. 2015;167A(1):11–25.CrossRef Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, et al. International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A. 2015;167A(1):11–25.CrossRef
31.
go back to reference Trowbridge JM, Gallo RL. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology. 2002;12:117R–25R.CrossRef Trowbridge JM, Gallo RL. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology. 2002;12:117R–25R.CrossRef
32.
go back to reference Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. Mucopolysaccharidosis VI. Orphanet J Rare Dis. 2010;5:5.CrossRef Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. Mucopolysaccharidosis VI. Orphanet J Rare Dis. 2010;5:5.CrossRef
33.
go back to reference Fiumara A, Sorge G, Del Campo G, Trigilia C, Barone R. Hurler disease (MPS): evidence for the need of increased awareness by different specialists. Mol Genet Metab. 2013;108:s40.CrossRef Fiumara A, Sorge G, Del Campo G, Trigilia C, Barone R. Hurler disease (MPS): evidence for the need of increased awareness by different specialists. Mol Genet Metab. 2013;108:s40.CrossRef
34.
go back to reference Peake RW, Bodamer OA. Newborn screening for lysosomal storage disorders. J Pediatr Genet. 2017;6(1):51–60.CrossRef Peake RW, Bodamer OA. Newborn screening for lysosomal storage disorders. J Pediatr Genet. 2017;6(1):51–60.CrossRef
Metadata
Title
Mucopolysaccharidoses: early diagnostic signs in infants and children
Authors
Cinzia Galimberti
Annalisa Madeo
Maja Di Rocco
Agata Fiumara
Publication date
01-11-2018
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue Special Issue 2/2018
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-018-0550-5

Other articles of this Special Issue 2/2018

Italian Journal of Pediatrics 2/2018 Go to the issue